Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Tuning of natural killer cell reactivity by NKp46 and Helios calibrates T cell responses.

Narni-Mancinelli E, Jaeger BN, Bernat C, Fenis A, Kung S, De Gassart A, Mahmood S, Gut M, Heath SC, Estellé J, Bertosio E, Vely F, Gastinel LN, Beutler B, Malissen B, Malissen M, Gut IG, Vivier E, Ugolini S.

Science. 2012 Jan 20;335(6066):344-8. doi: 10.1126/science.1215621.

2.

The natural cytotoxicity receptor NKp46 is dispensable for IL-22-mediated innate intestinal immune defense against Citrobacter rodentium.

Satoh-Takayama N, Dumoutier L, Lesjean-Pottier S, Ribeiro VS, Mandelboim O, Renauld JC, Vosshenrich CA, Di Santo JP.

J Immunol. 2009 Nov 15;183(10):6579-87. doi: 10.4049/jimmunol.0901935. Epub 2009 Oct 21.

3.

Enhanced in vivo growth of lymphoma tumors in the absence of the NK-activating receptor NKp46/NCR1.

Halfteck GG, Elboim M, Gur C, Achdout H, Ghadially H, Mandelboim O.

J Immunol. 2009 Feb 15;182(4):2221-30. doi: 10.4049/jimmunol.0801878.

4.

Recognition and prevention of tumor metastasis by the NK receptor NKp46/NCR1.

Glasner A, Ghadially H, Gur C, Stanietsky N, Tsukerman P, Enk J, Mandelboim O.

J Immunol. 2012 Mar 15;188(6):2509-15. doi: 10.4049/jimmunol.1102461. Epub 2012 Feb 3.

5.

NKp46 regulates allergic responses.

Ghadially H, Horani A, Glasner A, Elboim M, Gazit R, Shoseyov D, Mandelboim O.

Eur J Immunol. 2013 Nov;43(11):3006-16. doi: 10.1002/eji.201343388. Epub 2013 Aug 21.

6.

Conditional ablation of NKp46+ cells using a novel Ncr1(greenCre) mouse strain: NK cells are essential for protection against pulmonary B16 metastases.

Merzoug LB, Marie S, Satoh-Takayama N, Lesjean S, Albanesi M, Luche H, Fehling HJ, Di Santo JP, Vosshenrich CA.

Eur J Immunol. 2014 Nov;44(11):3380-91. doi: 10.1002/eji.201444643. Epub 2014 Sep 19.

7.

Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense.

Satoh-Takayama N, Vosshenrich CA, Lesjean-Pottier S, Sawa S, Lochner M, Rattis F, Mention JJ, Thiam K, Cerf-Bensussan N, Mandelboim O, Eberl G, Di Santo JP.

Immunity. 2008 Dec 19;29(6):958-70. doi: 10.1016/j.immuni.2008.11.001. Epub 2008 Dec 11.

8.

Rat NKp46 activates natural killer cell cytotoxicity and is associated with FcepsilonRIgamma and CD3zeta.

Westgaard IH, Berg SF, Vaage JT, Wang LL, Yokoyama WM, Dissen E, Fossum S.

J Leukoc Biol. 2004 Dec;76(6):1200-6. Epub 2004 Sep 8.

9.

Identification of the amino acid sequence motif for conventional PKC-mediated regulation of NKp46 surface expression.

Kim HR, Chwae YJ, Kim J.

Scand J Immunol. 2010 Jun;71(6):413-9. doi: 10.1111/j.1365-3083.2010.02395.x.

10.

Transgenic expression of the activating natural killer receptor Ly49H confers resistance to cytomegalovirus in genetically susceptible mice.

Lee SH, Zafer A, de Repentigny Y, Kothary R, Tremblay ML, Gros P, Duplay P, Webb JR, Vidal SM.

J Exp Med. 2003 Feb 17;197(4):515-26.

11.

Initiation and limitation of Ly-49A NK cell receptor acquisition by T cell factor-1.

Ioannidis V, Kunz B, Tanamachi DM, Scarpellino L, Held W.

J Immunol. 2003 Jul 15;171(2):769-75.

13.

Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46.

Walzer T, Bléry M, Chaix J, Fuseri N, Chasson L, Robbins SH, Jaeger S, André P, Gauthier L, Daniel L, Chemin K, Morel Y, Dalod M, Imbert J, Pierres M, Moretta A, Romagné F, Vivier E.

Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3384-9. Epub 2007 Feb 20.

14.

Fate mapping analysis of lymphoid cells expressing the NKp46 cell surface receptor.

Narni-Mancinelli E, Chaix J, Fenis A, Kerdiles YM, Yessaad N, Reynders A, Gregoire C, Luche H, Ugolini S, Tomasello E, Walzer T, Vivier E.

Proc Natl Acad Sci U S A. 2011 Nov 8;108(45):18324-9. doi: 10.1073/pnas.1112064108. Epub 2011 Oct 21.

15.

The NK receptor KLRG1 is dispensable for virus-induced NK and CD8+ T-cell differentiation and function in vivo.

Gründemann C, Schwartzkopff S, Koschella M, Schweier O, Peters C, Voehringer D, Pircher H.

Eur J Immunol. 2010 May;40(5):1303-14. doi: 10.1002/eji.200939771.

16.

Targeting natural killer cell reactivity by employing antibody to NKp46: implications for type 1 diabetes.

Yossef R, Gur C, Shemesh A, Guttman O, Hadad U, Nedvetzki S, Miletić A, Nalbandyan K, Cerwenka A, Jonjic S, Mandelboim O, Porgador A.

PLoS One. 2015 Feb 26;10(2):e0118936. doi: 10.1371/journal.pone.0118936. eCollection 2015.

17.

Expression, Function, and Molecular Properties of the Killer Receptor Ncr1-Noé.

Glasner A, Simic H, Miklić K, Roth Z, Berhani O, Khalaila I, Jonjic S, Mandelboim O.

J Immunol. 2015 Oct 15;195(8):3959-69. doi: 10.4049/jimmunol.1501234. Epub 2015 Sep 14.

PMID:
26371250
18.

The activating receptor NKp46 is essential for the development of type 1 diabetes.

Gur C, Porgador A, Elboim M, Gazit R, Mizrahi S, Stern-Ginossar N, Achdout H, Ghadially H, Dor Y, Nir T, Doviner V, Hershkovitz O, Mendelson M, Naparstek Y, Mandelboim O.

Nat Immunol. 2010 Feb;11(2):121-8. doi: 10.1038/ni.1834. Epub 2009 Dec 20.

PMID:
20023661
19.

IL-7 and IL-15 independently program the differentiation of intestinal CD3-NKp46+ cell subsets from Id2-dependent precursors.

Satoh-Takayama N, Lesjean-Pottier S, Vieira P, Sawa S, Eberl G, Vosshenrich CA, Di Santo JP.

J Exp Med. 2010 Feb 15;207(2):273-80. doi: 10.1084/jem.20092029. Epub 2010 Feb 8.

20.

NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies.

Magri G, Muntasell A, Romo N, Sáez-Borderías A, Pende D, Geraghty DE, Hengel H, Angulo A, Moretta A, López-Botet M.

Blood. 2011 Jan 20;117(3):848-56. doi: 10.1182/blood-2010-08-301374. Epub 2010 Oct 28.

Items per page

Supplemental Content

Write to the Help Desk